These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2971114)

  • 21. Thyroid function and plasma immunoglobulins in subjects with Down's syndrome (DS) during ontogenesis and zinc therapy.
    Sustrová M; Strbák V
    J Endocrinol Invest; 1994 Jun; 17(6):385-90. PubMed ID: 7930384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.
    Karttunen R; Nurmi T; Ilonen J; Surcel HM
    Clin Exp Immunol; 1984 Feb; 55(2):257-63. PubMed ID: 6230181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.
    Maccario R; Ugazio AG; Nespoli L; Alberini C; Montagna D; Porta F; Bonetti F; Burgio GR
    Clin Exp Immunol; 1984 Jul; 57(1):220-6. PubMed ID: 6235075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome.
    Cetiner S; Demirhan O; Inal TC; Tastemir D; Sertdemir Y
    Int J Immunogenet; 2010 Aug; 37(4):233-7. PubMed ID: 20477881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The immunological profile of children with Down's syndrome].
    Colombo ML; Girardo E; Saitta M; Ricci BM; Maina D
    Minerva Pediatr; 1989 Jan; 41(1):1-4. PubMed ID: 2525223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc and immune function in Down's syndrome.
    Björkstén B; Bäck O; Gustavson KH; Hallmans G; Hägglöf B; Tärnvik A
    Acta Paediatr Scand; 1980 Mar; 69(2):183-7. PubMed ID: 6445155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help.
    Verstegen RH; Kusters MA; Gemen EF; DE Vries E
    Pediatr Res; 2010 May; 67(5):563-9. PubMed ID: 20098344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects.
    Lew F; Tsang P; Solomon S; Selikoff IJ; Bekesi JG
    J Clin Lab Immunol; 1984 Jul; 14(3):115-21. PubMed ID: 6237206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological patterns in young children with Down syndrome: is there a temporal trend?
    Cocchi G; Mastrocola M; Capelli M; Bastelli A; Vitali F; Corvaglia L
    Acta Paediatr; 2007 Oct; 96(10):1479-82. PubMed ID: 17727689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Pattern of Malignancies in Down Syndrome and Its Potential Context With the Immune System.
    Satgé D; Seidel MG
    Front Immunol; 2018; 9():3058. PubMed ID: 30631328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological studies of patients with Down's syndrome. Measurements of autoantibodies and serum antibodies to dietary antigens in relation to zinc levels.
    Kanavin O; Scott H; Fausa O; Ek J; Gaarder PI; Brandtzaeg P
    Acta Med Scand; 1988; 224(5):473-7. PubMed ID: 2974234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency.
    Allen JI; Perri RT; McClain CJ; Kay NE
    J Lab Clin Med; 1983 Oct; 102(4):577-89. PubMed ID: 6604771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte surface phenotypes in Down's syndrome.
    Bertotto A; Lungarotti MS; Gentili F; Vaccaro R
    Int J Tissue React; 1984; 6(3):219-21. PubMed ID: 6237071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of lymphocyte beta-adrenergic receptor in Down's syndrome: a biological marker of a neuroimmune deficit.
    Morale MC; Batticane N; Cioni M; Marchetti B
    J Neuroimmunol; 1992 Jun; 38(3):185-98. PubMed ID: 1318320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro immune cell function in six cases of immunoproliferative small intestinal disease after long term remission.
    López-Botet M; Chantar C; Plaza A; Abreu L; Kreisler M; de Landázuri MO
    Clin Exp Immunol; 1983 Sep; 53(3):663-71. PubMed ID: 6225578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of plasma zinc levels in patients with Down syndrome].
    Rascón Trincado MV; Lorente Toledano F; Salazar A-Villalobos V
    An Esp Pediatr; 1992 Nov; 37(5):391-3. PubMed ID: 1456622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer cell function in trisomy-21 (Down's syndrome).
    Nurmi T; Huttunen K; Lassila O; Henttonen M; Säkkinen A; Linna SL; Tiilikainen A
    Clin Exp Immunol; 1982 Mar; 47(3):735-41. PubMed ID: 6177458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of age-associated LFA-1 up-regulation and impaired ICAM-1 binding in lymphocytes from patients with Down syndrome.
    Lin SJ; Wang JY; Klickstein LB; Chuang KP; Chen JY; Lee JF; Shieh CC
    Clin Exp Immunol; 2001 Oct; 126(1):54-63. PubMed ID: 11678899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T and B lymphocytes in patients with Down's syndrome.
    Reiser K; Whitcomb C; Robinson K; MacKenzie MR
    Am J Ment Defic; 1976 May; 80(6):613-9. PubMed ID: 134638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proapoptotic activated T-cells in the blood of children with Down's syndrome: relationship with dietary antigens and intestinal alterations.
    Corsi MM; Ponti W; Venditti A; Ferrara F; Baldo C; Chiappelli M; Licastro F
    Int J Tissue React; 2003; 25(3):117-25. PubMed ID: 14756193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.